These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1385997)

  • 1. Cell cycle control in normal and neoplastic cells.
    Morgan DO
    Curr Opin Genet Dev; 1992 Feb; 2(1):33-7. PubMed ID: 1385997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age.
    Hunter T; Pines J
    Cell; 1994 Nov; 79(4):573-82. PubMed ID: 7954824
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle.
    Musgrove EA; Lee CS; Buckley MF; Sutherland RL
    Proc Natl Acad Sci U S A; 1994 Aug; 91(17):8022-6. PubMed ID: 8058751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential control of cyclins D1 and D3 and the cdk inhibitor p27Kip1 by diverse signalling pathways in Swiss 3T3 cells.
    Mann DJ; Higgins T; Jones NC; Rozengurt E
    Oncogene; 1997 Apr; 14(15):1759-66. PubMed ID: 9150381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1.
    Lukas J; Müller H; Bartkova J; Spitkovsky D; Kjerulff AA; Jansen-Dürr P; Strauss M; Bartek J
    J Cell Biol; 1994 May; 125(3):625-38. PubMed ID: 8175885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of cell cycle entry and G1 progression by CSF-1.
    Roussel MF
    Mol Reprod Dev; 1997 Jan; 46(1):11-8. PubMed ID: 8981358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression.
    Jiang W; Kahn SM; Zhou P; Zhang YJ; Cacace AM; Infante AS; Doi S; Santella RM; Weinstein IB
    Oncogene; 1993 Dec; 8(12):3447-57. PubMed ID: 8247550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16.
    Lukas J; Parry D; Aagaard L; Mann DJ; Bartkova J; Strauss M; Peters G; Bartek J
    Nature; 1995 Jun; 375(6531):503-6. PubMed ID: 7777060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytometry of cyclin proteins.
    Darzynkiewicz Z; Gong J; Juan G; Ardelt B; Traganos F
    Cytometry; 1996 Sep; 25(1):1-13. PubMed ID: 8875049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D-type cyclins.
    Sherr CJ
    Trends Biochem Sci; 1995 May; 20(5):187-90. PubMed ID: 7610482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory genes and drug sensitivity.
    Kohn KW
    J Natl Cancer Inst; 1996 Sep; 88(18):1255-6. PubMed ID: 8797761
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclin gene expression and growth control in normal and neoplastic human breast epithelium.
    Sutherland RL; Watts CK; Musgrove EA
    J Steroid Biochem Mol Biol; 1993 Dec; 47(1-6):99-106. PubMed ID: 8274447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin D1 expression is a major target of the cAMP-induced inhibition of cell cycle entry in fibroblasts.
    L'Allemain G; Lavoie JN; Rivard N; Baldin V; Pouyssegur J
    Oncogene; 1997 Apr; 14(16):1981-90. PubMed ID: 9150365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G1 cyclins and control of the cell division cycle in normal and transformed cells.
    Hamel PA; Hanley-Hyde J
    Cancer Invest; 1997; 15(2):143-52. PubMed ID: 9095210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclins and cell cycle checkpoints.
    Johnson DG; Walker CL
    Annu Rev Pharmacol Toxicol; 1999; 39():295-312. PubMed ID: 10331086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cyclins and proliferative pathology].
    Wołowiec D
    Acta Haematol Pol; 1994; 25(3):195-203. PubMed ID: 7992592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current concepts in neuro-oncology: the cell cycle--a review.
    Dirks PB; Rutka JT
    Neurosurgery; 1997 May; 40(5):1000-13; discussion 1013-5. PubMed ID: 9149259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The molecular basis of carcinogenesis: understanding the cell cycle clock.
    Weinberg RA
    Cytokines Mol Ther; 1996 Jun; 2(2):105-10. PubMed ID: 9384694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of G1 progression by D-type cyclins: key event for cell proliferation.
    Kato JY
    Leukemia; 1997 Apr; 11 Suppl 3():347-51. PubMed ID: 9209386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenic aberrations of p16INK4/CDKN2 and cyclin D1 cooperate to deregulate G1 control.
    Lukas J; Aagaard L; Strauss M; Bartek J
    Cancer Res; 1995 Nov; 55(21):4818-23. PubMed ID: 7585513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.